Posttraumatic Stress Disorder: Evaluation and Treatment

Area of Science:

• Psychiatry
• Psychology
• Neuroscience

Background:

• Posttraumatic stress disorder (PTSD) is a prevalent condition with a lifetime prevalence of approximately 6%.
• PTSD symptoms manifest after a traumatic event and include intrusive thoughts, avoidance, negative mood alterations, and changes in arousal.
• Early identification and treatment are crucial, with acute stress disorder preceding PTSD.

Purpose of the Study:

• To outline the diagnostic criteria and assessment tools for PTSD.
• To review current first-line and adjunctive treatment options for PTSD.
• To highlight the importance of addressing comorbidities and sleep disturbances in PTSD management.

Main Methods:

• Review of diagnostic criteria from the DSM-5.
• Utilizing the PTSD Checklist for DSM-5 for diagnosis and severity assessment.
• Analysis of treatment efficacy for psychotherapy and pharmacotherapy.

Main Results:

• Trauma-focused cognitive behavior therapy is a first-line psychotherapy for PTSD.
• SSRIs (fluoxetine, paroxetine, sertraline) and venlafaxine are effective pharmacotherapies for primary PTSD symptoms.
• Prazosin is effective for PTSD-related sleep disturbances; obstructive sleep apnea should be considered.

Conclusions:

• PTSD diagnosis relies on specific criteria and validated checklists.
• Integrated treatment approaches combining psychotherapy, pharmacotherapy, and management of comorbidities are essential.
• Addressing sleep disturbances, including potential obstructive sleep apnea, is vital for comprehensive PTSD care.